$JTAI
Jet.AI Inc. Stock $jtai

$jtai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224020008 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.084M	$3.849M	$0.00
YoY Change	10.42%
Cost Of Revenue	$3.501M	$3.973M	$1.951M
YoY Change	16.94%	103.69%
Gross Profit	-$417.0K	-$124.4K	-$75.02K
YoY Change	107.65%	65.77%
Gross Profit Margin	-13.52%	-3.23%
Selling, General & Admin	$2.766M	$2.993M	$363.7K
YoY Change	24.65%	723.01%	547.52%
% of Gross Profit
Research & Development	$37.40K	$32.55K	$36.32K
YoY Change	30.57%	-10.39%
% of Gross Profit
Depreciation & Amortization	$33.82K	$33.81K	$33.60K
YoY Change	0.68%	0.65%
% of Gross Profit
Operating Expenses	$2.804M	$3.025M	$363.7K
YoY Change	24.72%	731.96%	547.52%
Operating Profit	-$3.221M	-$3.150M	-$363.7K
YoY Change	2940.75%	766.15%	547.56%
Interest Expense	$0.00	$79.31K	-$251.6K
YoY Change		-131.53%	-107.35%
% of Operating Profit
Other Income/Expense, Net	$59.00	-$79.25K
YoY Change
Pretax Income	-$3.221M	-$3.229M	-$615.3K
YoY Change	31.52%	424.84%	-118.29%
Income Tax
% Of Pretax Income
Net Earnings	-$3.221M	-$3.229M	-$615.2K
YoY Change	-1486.2%	424.84%	-118.29%
Net Earnings / Revenue	-104.43%	-83.9%
Basic Earnings Per Share	-$0.25	-$0.28	-$0.15
Diluted Earnings Per Share	-$0.25	-$0.28	-$0.15
COMMON SHARES
Basic Shares Outstanding	12.72M shares	12.21M shares	4.177M shares
Diluted Shares Outstanding	12.91M shares	11.44M shares	4.177M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$528.1K	$595.6K	$13.04M
YoY Change	-95.98%	-95.43%	2251.67%
Cash & Equivalents	$528.1K	$595.6K	$66.39K
Short-Term Investments			$12.97M
Other Short-Term Assets	$72.77K	$104.7K	$13.00M
YoY Change	-60.87%	-99.19%	26612.72%
Inventory
Prepaid Expenses
Receivables	$536.0K	$163.0K
Other Receivables	$0.00	$1.500M
Total Short-Term Assets	$1.937M	$3.163M	$13.06M
YoY Change	134.99%	-75.78%	2066.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.329K	$6.967K
YoY Change	-99.66%
Goodwill
YoY Change
Intangibles	$20.40K	$53.58K
YoY Change
Long-Term Investments	$208.5K	$208.4K
YoY Change	31.64%
Other Assets	$689.8K	$689.8K
YoY Change	0.0%
Total Long-Term Assets	$2.237M	$2.402M	-$3.00
YoY Change	-81.9%	-80051400.0%	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$1.937M	$3.163M	$13.06M
Total Long-Term Assets	$2.237M	$2.402M	-$3.00
Total Assets	$4.174M	$5.565M	$13.06M
YoY Change	-68.33%	-57.4%	-88.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.515M	$1.386M
YoY Change	204.43%
Accrued Expenses	$2.749M	$2.444M	$340.2K
YoY Change	569.15%	618.5%	1126.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.881M	$5.740M	$340.2K
YoY Change	105.41%	1587.35%	444.34%
LONG-TERM LIABILITIES
Long-Term Debt	$1.702M	$1.702M	$575.0K
YoY Change		196.0%
Other Long-Term Liabilities	$760.5K	$891.4K	$4.784M
YoY Change	-40.5%	-81.37%	-37.66%
Total Long-Term Liabilities	$2.463M	$2.593M	$5.359M
YoY Change	92.65%	-51.61%	-30.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.881M	$5.740M	$340.2K
Total Long-Term Liabilities	$2.463M	$2.593M	$5.359M
Total Liabilities	$8.344M	$8.333M	$5.699M
YoY Change	49.36%	46.21%	-26.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$45.72M	-$42.50M	-$5.608M
YoY Change	726.73%	657.85%
Common Stock	$1.475K	$1.255K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.170M	-$2.768M	-$5.608M
YoY Change
Total Liabilities & Shareholders Equity	$4.174M	$5.565M	$13.06M
YoY Change	-68.33%	-57.4%	-88.87%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.221M	-$3.229M	-$615.2K
YoY Change	-1486.2%	424.84%	-118.29%
Depreciation, Depletion And Amortization	$33.82K	$33.81K	$33.60K
YoY Change	0.68%	0.65%
Cash From Operating Activities	-$2.185M	-$2.521M	-$145.3K
YoY Change	200.43%	1634.56%	142.13%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$4.339K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$100.00	$0.00
YoY Change	-99.34%
Cash From Investing Activities	-$100.00	-$12.92K	-$93.63K
YoY Change	-99.64%	-86.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.449M	$1.029M	$1.152M
YoY Change	25.77%	-10.68%
NET CHANGE
Cash From Operating Activities	-2.185M	-$2.521M	-$145.3K
Cash From Investing Activities	-100.0	-$12.92K	-$93.63K
Cash From Financing Activities	1.449M	$1.029M	$1.152M
Net Change In Cash	-736.2K	-$1.505M	-$145.3K
YoY Change	-2.52%	935.59%	142.13%
FREE CASH FLOW
Cash From Operating Activities	-$2.185M	-$2.521M	-$145.3K
Capital Expenditures	$0.00		$4.339K
Free Cash Flow	-$2.185M	-$2.521M	-$149.7K
YoY Change	195.2%	1584.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001861622
CY2023Q4	JTAI	Subscription Receivable SubscriptionReceivable		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2024Q1	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	595555	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	162962	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	104657	usd
CY2024Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	800000	usd
CY2024Q1	JTAI	Subscription Receivable SubscriptionReceivable	1500025	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3163199	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3187153	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6967	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7604	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53577	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73831	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1442884	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1572489	usd
CY2024Q1	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	100000	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	100000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	798111	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	798111	usd
CY2024Q1	us-gaap	Assets Assets	5564738	usd
CY2023Q4	us-gaap	Assets Assets	5739188	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1386436	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1656965	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2444004	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2417115	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1395285	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1779794	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	513869	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	510034	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5739594	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6951897	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	891415	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1021330	usd
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1702000	usd
CY2023Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1702000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	8333009	usd
CY2023Q4	us-gaap	Liabilities Liabilities	9675227	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12555144	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12555144	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9754364	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9754364	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1255	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	975	usd
CY2024Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	6724	usd
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	6724	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39738635	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35342098	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42501437	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39272388	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2768271	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3936039	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5564738	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5739188	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-124356	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-75018	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1199318	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	446600	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	120167	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32546	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36319	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3025440	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2644504	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3149796	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2719522	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	79314	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	61	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79253	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3229049	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2719522	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3229049	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2719522	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	29728	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3258777	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2719522	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11441443	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11441443	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3902489	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3902489	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	736293	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1407044	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1512260	usd
CY2023Q1	JTAI	Stock Issued During Period Value Receipt Of Subscription Receivable StockIssuedDuringPeriodValueReceiptOfSubscriptionReceivable	76435	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	436969	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2719522	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	575541	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3936039	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3936039	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1199318	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1500025	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1500025	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	155000	usd
CY2024Q1	JTAI	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	742474	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1110000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3229049	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2768271	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2768271	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3229049	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2719522	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33813	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33596	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	80761	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1199318	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1407044	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	129605	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	125884	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	66423	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-85414	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	98571	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-270529	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	22105	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	26889	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-192625	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-384509	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	352401	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-126080	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-122359	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2520790	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1192047	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4339	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12922	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4294	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	100000	usd
CY2023Q1	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	15000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12922	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93633	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	371250	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	297500	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	155000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	436969	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	742474	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1110000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1588695	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1028724	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1151726	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1504988	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-133954	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2100543	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1527391	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	595555	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1393437	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	79314	usd
CY2024Q1	JTAI	Subscription Receivable From Sale Of Common And Preferred Stock SubscriptionReceivableFromSaleOfCommonAndPreferredStock	1500025	usd
CY2023Q1	JTAI	Subscription Receivable From Sale Of Common And Preferred Stock SubscriptionReceivableFromSaleOfCommonAndPreferredStock	9935	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zIjFsPFIQddg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zDOOhJSP4vee">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentImpairment_zIek4TM2ERlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zdYasZaySJ03">Property and Equipment</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost, less accumulated depreciation. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. As of March 31, 2024 and December 31, 2023, property and equipment consisted entirely of equipment which is being depreciated over a <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20240331_z2vpfVyHDejh" title="Useful lives::XDX::P3Y"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231_zPwxFN7QxFFe" title="Useful lives::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0593"><span style="-sec-ix-hidden: xdx2ixbrl0595">three</span></span></span></span>-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	398108	usd
CY2023	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	398108	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	33176	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	33176	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	431276	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3848598	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1875508	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	446600	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	120167	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1021330	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1405284	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1531364	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zXHOLroypdd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zW2r4iUOUtI9">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with several major financial institutions located in the United States of America which it believes to be creditworthy. Balances are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240331_zuqi0YCl8rSb" title="Cash FDIC insured amount">250,000</span>. At times, the Company may maintain balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	108361	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	108361	usd
CY2024Q1	JTAI	Lease Maintenance Reserve LeaseMaintenanceReserve	689750	usd
CY2023Q4	JTAI	Lease Maintenance Reserve LeaseMaintenanceReserve	689750	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	798111	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	798111	usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	112500	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2023Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-03-11
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	181250	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	90625	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	79314	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	320775	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	548049	usd
CY2024Q1	JTAI	Operating Lease Right Of Use Of Asset OperatingLeaseRightOfUseOfAsset	2576036	usd
CY2023Q4	JTAI	Operating Lease Right Of Use Of Asset OperatingLeaseRightOfUseOfAsset	2576036	usd
CY2024Q1	JTAI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1133152	usd
CY2023Q4	JTAI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1003547	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1442884	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1572489	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	513869	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	510034	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	891415	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	411750	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	549000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	503250	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1464000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	58716	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1405284	usd
CY2023Q3	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	625000	usd
CY2023Q3	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	59000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3284488	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1199318	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1407044	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3490329	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3216408	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.48
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y21D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68080	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.42
CY2023Q1	JTAI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P10Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3284488	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.56
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M6D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3659015	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.19
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3659015	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.19
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3120585	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.29
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M13D
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-841375	usd
CY2024Q1	JTAI	Revenue From Current Period Sales RevenueFromCurrentPeriodSales	-1867797	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1395285	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	25221406	shares
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1779794	usd
CY2024Q1	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	2324663	usd

Files In Submission

Name	View Source	Status
0001493152-24-020008-index-headers.html	Edgar Link	pending
0001493152-24-020008-index.html	Edgar Link	pending
0001493152-24-020008.txt	Edgar Link	pending
0001493152-24-020008-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
jtai-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jtai-20240331_cal.xml	Edgar Link	unprocessable
jtai-20240331_def.xml	Edgar Link	unprocessable
jtai-20240331_lab.xml	Edgar Link	unprocessable
jtai-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JTAI
Jet.AI Inc. Stock $jtai

2024 Q2 Form 10-Q Financial Statement

#000149315224020008 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JTAI Jet.AI Inc. Stock $jtai

2024 Q2 Form 10-Q Financial Statement

#000149315224020008 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JTAI
Jet.AI Inc. Stock $jtai